<SEC-DOCUMENT>0001104659-20-061590.txt : 20200514
<SEC-HEADER>0001104659-20-061590.hdr.sgml : 20200514
<ACCEPTANCE-DATETIME>20200514160531
ACCESSION NUMBER:		0001104659-20-061590
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20200514
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200514
DATE AS OF CHANGE:		20200514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		20877717

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2019515d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B></B>&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
May 14, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applied DNA Sciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center">(State or other jurisdiction<BR>
        of incorporation)</P></TD>
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>001-36745</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><B>59-2262718</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices;
zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; background-color: white; color: #231F20">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; background-color: white; color: #231F20"><FONT STYLE="background-color: white">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 29%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Title of each class</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Trading </B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
<FONT STYLE="color: #231F20">Symbol(s)</FONT></FONT></B></TD>
    <TD STYLE="width: 1%; padding-bottom: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 53%; border-bottom: black 1pt solid; padding-bottom: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Name of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, $0.001 par value</FONT></TD>
    <TD STYLE="padding-bottom: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APDN</FONT></TD>
    <TD STYLE="padding-bottom: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2.02&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 14, 2020, Applied DNA Sciences, Inc. (the &ldquo;Company&rdquo;)
issued a press release announcing its results of operations for the fiscal second quarter ended March 31, 2020. A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information furnished pursuant to this Item 2.02, including
Exhibit 99.1, shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities under that Section and will not be deemed to be incorporated
by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as will be
expressly set forth by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; padding-right: 0.8pt"><A HREF="tm2019515d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="width: 94%; padding-right: 0.8pt; text-align: justify"><A HREF="tm2019515d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Applied DNA Sciences, Inc. dated March 14, 2020 regarding results of operations for the fiscal second quarter ended March 31, 2020.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.65pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May 14, 2020</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 1.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 45%; padding-right: 0.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%; border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 87%; border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt"><A HREF="tm2019515d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><A HREF="tm2019515d1_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Applied DNA Sciences, Inc. dated May 14, 2020 regarding results of operations for the fiscal second quarter ended March 31, 2020.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2019515d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT><IMG SRC="tm2019515d1_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Applied DNA Reports 2020 Fiscal Second
Quarter Financial Results</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Company to Hold Conference Call and Webcast
Today,<BR>
Thursday, May 14, 2020, at 4:30 p.m. EDT</I></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">STONY BROOK, N.Y. &ndash; May 14, 2020 &ndash;
Applied DNA Sciences Inc. (N<FONT STYLE="text-transform: lowercase">ASDAQ</FONT>: APDN) (&ldquo;Applied DNA&rdquo; or the &ldquo;Company&rdquo;)
a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables <I>in vitro</I> diagnostics, pre-clinical nucleic
acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced
consolidated financial results for the fiscal second quarter and the six months ended March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&ldquo;Continued execution on our strategic
priorities in our second fiscal quarter resulted in an expansion of our linear DNA story to include COVID-19 vaccine candidate
and diagnostic kit programs and the addition of new development customers. These new development customers, several of which are
leaders in the field of gene and redirected-cell therapies, demonstrate broadening interest and adoption of our proprietary linear
DNA approach to preclinical biotherapeutics and diagnostics development and further validate linear DNA as a viable alternative
for plasmid DNA,&rdquo; stated Dr. James A. Hayward, president and CEO of Applied DNA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&ldquo;Most of our activities during the quarter
were devoted to our COVID-19 development programs that serve to also elevate the profile of our PCR-based LinearDNA&trade; platform
to the biopharma industry as a powerful, large-scale tool for the rapid manufacture of DNA-based therapeutics,&rdquo; continued
Dr. Hayward. &ldquo;The global focus on the pandemic and the speed with which vaccine candidates are being developed are laying
bare the limitations of modern vaccine development that are almost-exclusively reliant on plasmid-based technologies that are often
slow and require much more downstream processing. Because our linear DNA approach does not require bacterial fermentation and has
the added advantage of essentially no risk of contamination by genes for antibiotic resistance and other genetic contaminants,
we believe our platform is well suited for such DNA-based therapeutics as engineered T cells, gene therapies, RNAi, and vaccines,
such as for COVID-19 or future emerging infectious diseases. One new development customer, a global Top-20 pharmaceutical manufacturer,
is evaluating the full scope of our platform to potentially serve as a foundational tool for their future genetic therapy pipeline.
As the industry comes to terms with the limitations of plasmid-based technologies in terms of production speed and risk, we believe
this will set the stage for a paradigm shift towards the rapid manufacturing of linear DNA vaccines with our LinearDNA&trade; platform
as the accelerator.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">Concluded Dr. Hayward, &ldquo;Looking ahead,
we remain focused on driving interest and building demand for our linear DNA approach across certain highly-regulated markets,
such as drug development, that we believe offer a path to higher and more recurring revenue. Takis Biotech (&ldquo;Takis&rdquo;)
has initiated preclinical animal trials of our LinearDNA&trade; version of their vaccine candidates that we believe will demonstrate similar,
robust immune responses to their plasmid-based constructs, but with the added advantage of speed and scalability to manufacture
for global use. Concurrently, we are preparing for the possibility for Takis to progress to human trials this fall by readying
our facility for compliance with the FDA&rsquo;s cGMP regulations that govern the quality of biologics for human use. We have also
developed our Linea&trade; COVID-19 high-throughput and high-sensitivity SARS-CoV-2 detection kit to enable mass-testing that can
be a crucial tool in the toolbox of health systems and governments in the fight to further &lsquo;flatten the curve&rsquo;. Having
received Emergency Use Authorization from the FDA today, we are now focused on the commercialization of our kit to assist frontline
workers leading the charge against the pandemic. Pharmaceutical molecular tagging is another target market and one where the FDA
has granted us entry into its Emerging Technology Program that gives us a path to drive the industry&rsquo;s adoption of our authentication
technologies and mitigate participation of counterfeit and adulterated drugs in the legitimate pharmaceutical supply chain. We
will continue to build our business development pipeline and execute on our strategy to advance and prove the capabilities of linear
DNA to drug developers and the broader pharmaceutical industry.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0A0A0A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A"><B>Fiscal Second Quarter
2020 Financial Results:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues decreased 29% for the second quarter of fiscal 2020 to $552
thousand, compared with $778 thousand reported in the same period of the prior fiscal year and decreased 13% from $634 for the
first quarter of fiscal 2020. This decrease in revenues year over year is due to a decrease of $305 thousand in service revenues,
offset by an increase of $79 thousand in product revenues. The decrease in service revenues is primarily attributable to a decrease
from a government contract award that ended during the second half of fiscal 2019 and a decline in precommercial feasibility projects
in both textiles and cannabis. The increase in product revenues was primarily related to an increase in biopharmaceutical revenues
during the quarter ended March 31, 2020.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses decreased to $3.1 million for the second
fiscal quarter of 2020, compared with $3.3 million in the prior fiscal year&rsquo;s second quarter. This decrease is attributable
to a decrease in professional fees of approximately $183 thousand due to reduced legal fees. To a lesser extent, the decrease relates
to a reduction of approximately $64 thousand in travel fees as result of travel restrictions associated with COVID-19. This decrease
was offset by an increase in research and development expenses of $52 thousand.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the quarter ended March 31, 2020 was $3.0 million, or
$0.79 per share, compared with a net loss of $2.7 million, or $3.22 per share, for the quarter ended March 31, 2019, an increase
of 10%, and a net loss of $2.7 million, or $1.12 per share, for the quarter ended December 31, 2019.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #0A0A0A">Excluding non-cash expenses, Adjusted EBITDA was negative
$2.6 million and a negative $2.3 million for the quarters ended March 31, 2020 and 2019, respectively. See below for information
regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #0A0A0A">Cash was $8.7 million at March 31, 2020 that includes
the exercise of warrants associated with the November 15, 2019 underwritten public offering (&ldquo;the offering&rdquo;) totaling
approximately $2.8 million in net proceeds. Subsequent to March 31, 2020 the Company received a further $2.9 million of net proceeds
through the exercise of warrants associated with the offering. There are a total of approximately 1.5 million warrants outstanding
from the offering at May 14, 2020.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A"><B>Six Months Ended
March 31, 2020 Financial Results:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues decreased 29% for the first half of fiscal 2020 to $1.2 million,
compared with $1.7 million reported in the same period of the prior fiscal year. This decrease in revenue year over year is due
to a decrease of $472 thousand in service revenues and a decrease of $5 thousand in product revenues. The decrease in service revenues
is primarily attributable to a decrease from a government contract award that ended during the second half of fiscal 2019. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses decreased to $6.1 million for the six months
ended March 31, 2020, compared with $7.2 million in the prior fiscal year&rsquo;s first six months. This decrease is primarily
attributable to decreases in payroll of approximately $272 thousand, attributable to headcount reductions, a decrease in stock-based
compensation expense of approximately $262 thousand as well as decreases in legal and professional fees of $139 thousand, consulting
fees of $121 thousand, reduced travel expenses of $110 thousand and research and development of $93 thousand. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: #0A0A0A"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the six-month period ended March 31, 2020 was $5.6 million,
or $1.76 per share, compared with a net loss of $5.9 million, or $6.51 per share, for the six months ended March 31, 2019, an improvement
of 5%.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #0A0A0A">Excluding non-cash expenses, Adjusted EBITDA was negative
$5.0 million and a negative $4.9 million for the six months ended March 31, 2020 and 2019, respectively. See below for information
regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A"><B>Select Quarterly
Operational Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">Applied DNA progressed
its COVID-19 development program that spans both vaccine development and clinical diagnostic kit development:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On May 14, 2020, Applied DNA announced that it had received
                                                                                                             Emergency Use Authorization for its COVID-19 diagnostic Assay kit from the U.S. Food and Drug Administration
                                                                                                             (&ldquo;FDA&rdquo;). Clinical laboratories in the United States certified under Clinical Laboratory Improvement Amendments
                                                                                                             can immediately begin ordering and using the Linea<SUP>TM</SUP> COVID-19 assay kit to detect SARS-CoV-2, the virus that
                                                                                                             causes COVID-19; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On May 5, 2020, the Company announced that it had applied to the
                                                                                                             U.S. FDA for Emergency Use Authorization for its COVID-19 diagnostic kit, Linea&trade; COVID-19, a RT-PCR-based,
                                                                                                             high-sensitivity and high-throughput COVID-19 diagnostic test;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On May 4, 2020, Applied DNA and its COVID-19 development partner,
Takis, announced that the first injections of their DNA vaccine candidates against the Spike protein (&lsquo;S&rsquo; gene) of
the SARS-CoV-2 virus that causes the COVID-19 disease, have produced neutralizing antibodies in test animals. The studies were
completed at the renowned Lazzaro Spallanzani  National Institute for Infectious Diseases in Rome. These
initial results were obtained using plasmids (the templates for LinearDNA&trade;) to baseline results; Applied DNA&rsquo;s linear
DNA dose-response trials begin in the week of May 4, 2020;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On April 21, 2020, the Company signed an agreement with Stony Brook
University Hospital to validate and implement the Company&rsquo;s COVID-19 diagnostic test: Linea&trade; COVID-19. The diagnostic
test targets the SARS-CoV-2 Spike (S) gene, which is also the subject of the Company&rsquo;s COVID-19 vaccine development program;
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On April 15, 2020, Applied DNA announced that it had shipped five
linear DNA versions of COVID-19 vaccine candidates to its drug development partner, Takis, to support the immediate start of preclinical
animal testing. Shipment of the vaccine candidates follows Takis&rsquo; receipt of approval from Italy&rsquo;s Ministry of Health
to begin preclinical testing. Concurrent with Takis&rsquo; animal trials, Applied DNA is preparing for cGMP production of selected
vaccine candidate(s) to support human trials scheduled to begin this fall; and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On March 24, the Company announced that it had filed a provisional
patent application with the U.S. Patent and Trademark Office for a diagnostic assay for COVID-19.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">The Company&rsquo;s
LinearDNA&trade; platform for preclinical biotherapeutic (gene and redirected-cell therapies) and diagnostic applications development
continued to shift towards broader adoption:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On March 26, the Company announced that it had shipped CAR T amplicons
proprietary to a new development customer, the biologics subsidiary of a U.S.-based, global biopharmaceutical company, for use
in evaluating the use of linear DNA; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On March 20, Applied DNA announced the signing of a research agreement
with a new development customer, a global Top-20 pharmaceutical manufacturer, to evaluate the full scope of the Company&rsquo;s
linear DNA platform to potentially improve the efficacy and safety of the customer&rsquo;s CAR T therapy pipeline. The research
agreement includes the Company&rsquo;s patented technologies to maximize protein expression and unique linear DNA anti-CD19 CAR
T construct for the treatment of acute lymphocytic leukemia.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">The Company&rsquo;s
DNA tagging business for supply chain security continued to build awareness and adoption:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #0A0A0A">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On February 24, the Company announced the receipt of international
patents on its Beacon&reg; secure optical molecular market technologies in China, Canada, and the U.S., each a key market for brand
protection and assurance for Applied DNA;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On February 20, Applied DNA received Pareve kosher certification
                                                                                                             for products within its SigNature&reg; and CertainT&reg; brands from Orthodox Union, the world&rsquo;s largest and most
                                                                                                             widely recognized international kosher certification agency. Certification supports the Company&rsquo;s business development
                                                                                                             efforts in the food, pharmaceutical, and dietary supplements markets to maximize adoption of its molecular-based tagging
                                                                                                             platform; and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.7pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On February 19, the Company entered the dietary supplements market
with a multi-year contract with Nutrition21, a trusted developer and supplier of novel and clinically substantiated branded ingredients
for the nutritional supplement industry. Under the terms of the contract, the application of Applied DNA&rsquo;s CertainT platform
to Nutrition21&rsquo;s leading sports supplement, Nitrosigine&reg;, offers Nutrition21 the certainty of its ingredients all the
way through to their customers&rsquo; finished products and onto retail shelves and online stores. Separately, the two companies
signed an additional agreement to enable Nutrition21 to represent the CertainT platform throughout Nutrition21&rsquo;s extensive
network in the dietary supplement market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Fiscal Second Quarter 2020 Conference Call Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company will hold a conference call and webcast to discuss
its fiscal second quarter-end 2020 results on Thursday, May 14, 2020 at 4:30 PM EDT. To participate on the conference call, please
follow the instructions below. While every attempt will be made to answer investors&rsquo; questions on the Q&amp;A portion of
the call, due to the large number of expected participants, not all questions may be answered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To Participate: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll Free: 1-844-887-9402 </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: Black">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Participant
                                         Toll: 1-412-317-6798</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: Black">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Please
                                         ask to be joined to the Applied DNA call</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Live
webcast: </FONT><FONT STYLE="color: Black">https://services.choruscall.com/links/apdn200507.html</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black"><B>Replay (available 1 hour following
the conclusion of the live call through May 21, 2020): </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: Black">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Participant
                                         Toll Free: 1-877-344-7529</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: Black">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Participant
                                         Toll: 1-412-317-0088</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: Black">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Participant
                                         Passcode: 10141899</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: Black">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Webcast
                                         replay: </FONT><FONT STYLE="color: Black">https://services.choruscall.com/links/apdn200507.html</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: Black">For those unable to attend
the live call, a copy of management&rsquo;s PowerPoint presentation will be available for review under the &lsquo;Events and Presentations&rsquo;
section of the company&rsquo;s Investor Relations web site: https://adnas.com/molecular-based-security/investors/</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black"><B>Information about Non-GAAP Financial
Measures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used herein, &ldquo;GAAP&rdquo; refers to accounting principles
generally accepted in the United States of America. To supplement our condensed consolidated financial statements prepared and
presented in accordance with GAAP, this earnings release includes Adjusted EBITDA, which is a non-GAAP financial measure as defined
in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a
numerical measure of a company&rsquo;s historical or future performance, financial position, or cash flows that either excludes
or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented
in accordance with GAAP. The presentation of this non-GAAP financial information is not intended to be considered in isolation
or as a substitute for, or superior to, the financial information presented in accordance with GAAP. We use this non-GAAP financial
measure for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons
of the performance and results of operations of our core business. Our management believes that these non-GAAP financial measures
provide meaningful supplemental information regarding the performance of our business by excluding non-cash expenses that may not
be indicative of our recurring operating results. We believe this non-GAAP financial measure is useful to investors as they allow
for greater transparency with respect to key metrics used by management in its financial and operational decision making.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;EBITDA&rdquo;- is defined as earnings (loss) before interest
expense, income tax expense and depreciation and amortization expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Adjusted EBITDA&rdquo;- is defined as EBITDA adjusted
to exclude (i) stock-based compensation and (ii) other non-cash expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2019515d1_ex99-1img02.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic
drug candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">Visit&nbsp;adnas.com&nbsp;for more
information. Follow us on&nbsp;Twitter&nbsp;and&nbsp;LinkedIn. Join our&nbsp;mailing list.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s common stock is listed on N<FONT STYLE="text-transform: lowercase">ASDAQ
</FONT>under ticker symbol &lsquo;APDN&rsquo;, and its publicly-traded warrants are listed on OTC under ticker symbol &lsquo;APPDW&rsquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: #0A0A0A; background-color: white"><B>Forward-Looking
Statements<FONT STYLE="font-family: Times New Roman, Times, Serif"><BR> </FONT></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">The
statements made by Applied DNA in this press release may be &ldquo;forward-looking&rdquo; in nature within the meaning of </FONT>Section
27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe Applied DNA&rsquo;s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the
control of Applied DNA. Actual results could differ materially from those projected due to the possibility of a failure to
make timely payment on its outstanding secured convertible notes and resulting enforcement by noteholders of remedies on
collateral which includes substantially all of Applied DNA&rsquo;s assets, its history of net losses, limited financial
resources, limited market acceptance, the uncertainties inherent in research and development, future clinical data and
analysis, including whether any of Applied DNA&rsquo;s or its partners therapeutic or diagnostic candidates will advance
further in the preclinical research or clinical trial process, including receiving clearance from the U.S. Food and Drug
Administration or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they
will receive final approval from the U.S. FDA or equivalent foreign regulatory agencies, the fact that there has never been a
commercial drug product utilizing PCR-produced DNA technology approved for therapeutic use, the unknown outcome of any
applications or requests to U.S. FDA or equivalent foreign regulatory agencies, the unknown limited duration of any Emergency
Use Authorization (EUA) approval from U.S. FDA, disruptions in the supply of raw materials and supplies, and various other
factors detailed from time to time in Applied DNA&rsquo;s SEC reports and filings, including our Annual Report on Form 10-K
filed on December 12, 2019 and our subsequent quarterly reports on Form 10-Q filed on February 6, 2020 and May 14, 2020, and
other reports we file with the SEC, which are available at&nbsp;www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events, unless otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2019515d1_ex99-1img03.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0070C0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: #0070C0"><B>Investor contact: </B></FONT>Sanjay
M. Hurry, 212-838-3777, LHA Investor Relations, <FONT STYLE="color: #0070C0"><B>shurry@lhai.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: #0070C0"><B>Web:</B></FONT> www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: #0070C0"><B>Twitter: </B></FONT>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Financial Tables Follow</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MARCH 31, 2020 AND <FONT STYLE="text-transform: uppercase">September
</FONT>30, 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">March 31, 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">September 30, 2019</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">ASSETS</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">8,662,889</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">558,988</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable, net of allowance of $4,500 at March 31, 2020 and September 30, 2019, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">549,123</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">839,951</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Inventories</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,941</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">142,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">678,120</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">604,740</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,979,073</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,146,308</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">265,400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">226,221</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred offering costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">109,698</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Deposits</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">76,085</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,351</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Goodwill</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">285,386</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">285,386</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Intangible assets, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">720,953</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">734,771</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,326,897</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,564,735</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">LIABILITIES AND EQUITY (DEFICIT)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable and accrued liabilities (including related party of $40,000 at March 31, 2020)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,178,358</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,616,997</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deferred revenue</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">671,526</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">628,993</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,849,884</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,245,990</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Long term accrued liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">722,564</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">621,970</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Secured convertible notes payable, related party, net of debt issuance costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,485,673</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,442,497</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Secured convertible notes payable, recorded at fair value</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">102,777</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,058,121</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,413,234</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Commitments and contingencies</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Applied DNA Sciences, Inc. Stockholders&rsquo; Equity (Deficit):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Series A Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2020 and September 30, 2019, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Series B Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- issued and outstanding as of March 31, 2020 and September 30, 2019, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Common stock, par value $0.001 per share; 500,000,000 shares authorized; 4,059,943 and 1,207,993 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,060</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,208</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Additional paid in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">269,693,833</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">255,962,922</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(262,423,267</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(256,805,589</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Applied DNA Sciences, Inc. stockholders&rsquo; equity (deficit):</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,274,626</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(841,459</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Noncontrolling interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,850</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,040</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total equity (deficit)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,268,776</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(848,499</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity (deficit)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,326,897</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,564,735</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See the accompanying notes to the condensed consolidated financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THREE AND SIX MONTHS ENDED MARCH 31,
2020 AND 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended March 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Six Months Ended March 31,</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2019</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Revenues:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%">Product</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">197,801</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">119,036</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">435,671</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">440,747</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Service</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">354,672</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">659,432</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">750,321</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,222,044</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">552,473</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">778,468</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,185,992</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,662,791</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Cost of revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">179,582</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">133,141</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">411,613</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">286,626</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Selling, general and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,285,544</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,528,914</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,658,957</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,611,295</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">703,018</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">651,377</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,267,444</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,360,941</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Depreciation and amortization</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">66,537</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">97,673</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">141,604</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">232,724</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,055,099</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,277,964</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,068,005</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,204,960</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">LOSS FROM OPERATIONS</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,682,208</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,632,637</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,293,626</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,828,795</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other (expense) income:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest (expense) income, net (including related parties interest of $25,840 and $49,310 for the three and six months ended March 31, 2019, respectively)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,096</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(37,417</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(58,187</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(69,028</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other expense, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(239,601</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(16,703</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(261,833</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(23,254</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Loss before provision for income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,950,905</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,686,757</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,613,646</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,921,077</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">NET LOSS</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,950,905</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,686,757</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,613,646</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,921,077</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Less: Net (income) loss attributable to noncontrolling interest</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,220</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,190</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">NET LOSS attributable to Applied DNA Sciences, Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,952,125</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,686,757</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,614,836</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,921,077</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deemed dividend related to warrant modifications</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,842</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">NET LOSS applicable to common stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,952,125</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,686,757</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,617,678</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,921,077</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss per share applicable to common stockholders-basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.79</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3.22</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1.76</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(6.51</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Weighted average shares outstanding-basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,758,512</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">834,990</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,196,616</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">909,623</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION AND RECONCILIATION OF ADJUSTED
EBITDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(unaudited)</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three Month Period Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">% &#8710;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; font-size: 10pt; text-align: left">Net Loss</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(2,950,905</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(2,686,757</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Interest expense (income), net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">29,096</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">37,417</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">66,537</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">97,673</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Stock based compensation expense (income)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">226,668</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">267,094</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">322,301</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">402,184</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(2,628,604</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(2,284,573</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">15</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Six Month Period Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">% &#8710;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Net Loss</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(5,613,646</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(5,921,077</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense (income), net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">58,187</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">69,028</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,604</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">232,724</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">432,758</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">757,338</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(8,633</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">632,549</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,050,457</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(4,981,097</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">(4,870,620</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right">2</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2019515d1_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2019515d1_ex99-1img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *@$. P$1  (1 0,1 ?_$ +L   $#! ,!
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M#PB[.WK-@E\[UVU9HB8J8*NW"39(3G'HI 46.0GN-^ =]CPBN0$# !BB!BF
M!*8! 0$!#L! 0]! 0X14P71,H*)5DC+%#LR0*$%0H?3L2 /N .Q_9PBHB_8@
M\+'B\: ^,G\I68N40=BF "/O!L)_F$G0?4"]<(NDA),(IL9[)/F4<R3_ 'KQ
M^Y1:-4Q$0 H*.5SIHD$PCZ (AW^'"+'[A>*O1:+:,C6:8:1].IU8FK?8)T%2
M*M&5?K\8YEY21!0AA(JFW8M#GZ*(^[KH/KPB^>#N)Y!]KO,+F21HU=5R-C;3
M2%LR!?[%8]IEINB<;4%':A(VYY3B:@F5U>;G,-FPN&L0NY09H&'V$ /8HH,B
MVUM7)[KO#:XZ6VA;& 7NF?T"CC0=.AJ:C7P"X.X-SX;:]G]5EOJ"Y]1&V*/U
M"XMU(/Q-Z10BAUJK'+GCCT]-481SKWD;?&)R!&134LBEEO4";D*E8YY GR'D
M(]Y45F,]4$EG(!\9"DDBH%Z$QC"'8V)'V-W0YSFMO\(]W3H!=@:\JGH5>'O7
MMEK!)+9Y9D=15QMM*<_Z:R?!?D0\W&H!6T)&IY=S;C:+Z;(5S,.)+MDR&4AF
MO1"(Q]B-!1]\A61FI>BI_<@1$!Z$@@'(;N'86=VN.K)&UD:/ZB;U?V0IG@-^
M[;W&0W'LO 3^M%3]I2FZ@_Q+&LM/2E*ML+JU<\#3R[]5_.RV)5UK]77$J4ZH
M"#RK69S"7"NC\RIQ^(/NDTS',(B ]\A-M+%<W MV=37N=0=8Z0/,U/X*77CA
M:0&X#)7M K0-U_%2J4GSRZ<9*CEI?'=)V6O<6V4*D[>4W#$A94V*IP Z2,E^
MD2CHT<X53'W FL!#]?ARX\?V1W-D+-N1AR&%$#Q5K7W08[[.@U\E4]YW>PF/
MNG6EY99$.'-L/4/Q% LP'S2:[>[VEP=N68WX=:XVD>QZ[Z "N!$1'FXSL1NA
MS2XY# M#176] )\OEZE8)>]6V(Z=-IE7U\+?3WGKT">+JGN50-NV-QD:#2<R
M4U"E/(MC))Y<QG-8]4?+2K=PX2/ FE/>E,)M_MC$<?&;M$_M 0_,'(!O'9>3
MV5=16U_-9W'JMJ#;RB4#S-!3BI=M#>MAO*TEN+&"Y@,3Z'U6=-?+5.[*/90'
M]O\ FY#V@AM'$$^(T4P!J*T(\UVYZ7U:J-4UUB_,+Y%/(9#;=Y3RFWQ!I=D6
M%PMAW7+']^F:%%)I+H2H.<DS2,8J5W(.992(%052I_TBKLA14]B*:8D7G:NY
M_P H^/VQ^8W4>NY8LF=<:Z-X4;YSURE\E3A[79:,]G:J^<KX]E9A8YS/8^OS
M#EI[FYO:FFJW4$J:0K'(!$G>"?%%CG9'QW,/(#E/:[85[N9D#$=AV%;[$M<R
MST?$8]LT8REI]G7&D,V=D8L(""5C2-GH%52525 X)?$4A4A(L4MNZ>R>Y>BW
MAYP9<LQV+"\OOIF.XXGV"S75WA*U;[11\3RPUXBD;*$%D1BZR*59(7JB9B)N
M7I/8(&3.HD8B5#:K52M>%K.6CN<])LI9C8M<S;%U# F9,#7[(TU?('+]4M*J
M*#^?",E!(J2:BRJ?F7(F)$'*Z*B0I"'1R+,\5G41WJ_B1ED3*HG2P#%F(L4Q
MDU 4#"-K4 Z9T11.0R0F_*8!]WT'OA%'-EK9K../?"[X@<$X[F,JMHC:&1OT
M+E-]B:541R_>:Q4;W*&_NPILZZ,H=M-W 9LWU.852-RIF**0J%$BN]6HK-^%
M-U]39;2+2SR*:NPMER;!TC8FN;175]:\19+QK+R+*/GYV3).MH5.-L4"S<KO
M3+%]Q"JE2^ "*_D.1/HUXU=K/F;V@W\R?N7E3+KZMZ\;#6+7W">O] R5-42*
MQC5ZT=RW8755E#@54\Q/?9=IK*)%*X=)+G4,H )ID(FQZIO[UH*'GK7Q9D2Q
MY-L6$[#AC'M5S!9GO]HK((R<E.P3*6G94YW:<A8J=#2_QK& 1Z69%'V%]OMY
M/>UV%Q^XNX&.PV3 DLY'N<Z(GI$O0.KI+J.IPIP-02%!NYF6R."V->Y7&.+;
MEG0T4XCK)'4/(5UY53U<P>,'$=?\>UJVB#/N8I7.ZV"O[VK7E.3RC-/ZY?U)
MR&0E96HS,.=Y]BY@)A-V,>D7Y3+&/T(@8WY>7WMSNSEKGNC:['%C:1;>BR B
MA@$='VP:XALC74&K:$\![N*HG.]M\9_YG/O2>^N79U]F92_U:Q.) ^'IK\1U
MI3QT7FVQ"VY1P9X3],U[?:Z#C#8*E$<9:0ILP\KT]8H&MUR,>,8!60:F(N2.
M50>*B!3 9,YSE,8#>P YLVAQ>+W1OW?5E:LN,ABKAKK5SP'MC<YTH+B#S!:-
M:Z"H2;ZR\V[L39YG=%;7T#A+J6.<&MBK0"M203TCG4)=\"0$CH%Y!]A=:L1V
M2ZV?!*^G,ML5 XWN=AD[8,'=ZV"@)-XAV]^5X/ZF=FHF?XP(90JQ0,4YR@;D
M9W3<P]QNUEAO',6]O;;L_P!Y%D98@&MF8=2YU!I3J'CJ"=."[^WA+LONK?[;
MQ-S/)@6X8W1B>>HQNY<Z$FGLX@),].-#*;Y"-;7NY.QV=<OSV><JR=WE(BSU
MG)4I7(3"9J_-2;*+BXN%8./T]LE%F:D=*(J?$0C8Y0(!0 #CT-^=Q+WMEN*+
MMSM3'6T.!MV0MG,D0,EV9&@R/KP(H:-\34D\EQ-G;"L^X&VYMY[@OY;C./DG
M?"YDI$<(;JUCQQK7ER%$AF37^\&[7AOK4;CEW><ZVO#NU*U)S97*'8WU=R%L
M+@7&C]9-S$-[#'N49-XO(-I)H9T5$ZSEZ@@"GL6/^0U7=[-HXO:?<)S<&T0V
M%Q8LE,9% UTE1TL'  =)IX55I=F-PWN;V37+/]?(0W1BZAK1HH02>= >*Q_7
M_<#6[6[Q[>37(NC&"\SZC[.8FIU&?9'UTS=9K/<7..IN7D?[$UW)E50MQG#M
M%HE_:!RX<E,D@)G+1 ZK8I3$]]2JV5(%XZO%YA_'6,L5[Z6C->;\^;/7;!4S
MD"=R):LMS,_2GDAEG';A6<8,:K[EHQ9&';RIFR1U5%%2.$C'_(/292*"N%VK
MSG@3P!X:A<36J[P$_GW=G+>)+/>:O(N3WJ,I*UAL$M*5VJ3+A<5XJ:MHQZ<>
MW5(H0Q"*'*0Q!-V!%B-*K^;,&Y?UXO\ HAHWY.-=<R,,G5"+R).[$7EU:,59
MNI\C(-VUJB\@QTHQBH5JX?('.X,HDJ9!%(QS@!3D34X12Z9#UYC/*?YA]P=?
MMF+]E-# NHV&L5GQCBW'M]E:;#(6R]QD4[E;7(C&=E>2S=X[<*%4.3W*](D$
M?A3]@D3-*9NQM+K+XBM]:)5\L6FR6S73>%WIQBG+]E?NI:[4+&EDL#&*5F5)
MA85%P>0;'[@C!<YA^Q,\+\0E^), (I''FC^/O%+IAL'OQA?(N9LU[31&JLP=
M7*&1LG35\JUAF+>6!>.[C&U!996)3:QLDJG((*?(L86[?HZARG.(D6M]5*]=
MKS@AAFZ+U5\L5TW)LD<?(<%O;7<E2JV/WMT</E7<?+0\,E&*,W./"F*5N8H.
M <"43>TQ.BI@12V;[4S>++V*?&=L-M/J]F#:G"55P-+_ .+76/$%OF*I.IYE
M<>]*/R-9FM'=/)!VH\@BMG()II*(M'::R)SH?)WPBF?\;L=IWLYXTGV,M<66
M1H37R[L<OXJM%!R1/RDWD3&,U<#R*5ZHC^9EW+QX=6N&L@&8C\RQ"(*)_F'H
M0 BTX,D5/R'>"7-EZQY"W#)E1PO?K'%A'Y7HC-HUJN9JS!?=)5^193$BSE(:
M#R)&Q#Q1%6.>JD]JPB4"&1$IN27;&>Q>W[QUUE<=#DK=P Z)#0-H:DBK7<>!
MT7$SN&OLW:BVL+^7'SBOQQMZBZHI0_$VE.*F"Q;OGAO)E4@)I3SF[/TVQRL6
MU?RN/;'KXW<6BL/G(""\._6B&#J(DEV;CLGRL55D5 Z$G0#T%UXG>>V-P3M@
MQ6Q<=++)1K0V< EQ-  /IZ5/FJ4SNW\[MN(G);LR@8T5Z_0ZFM UZG#UQ5HX
MD>"5(^S6."'^(_G8VB3.)3=%_P ,4L0P&^GJ"E?^I#?4O0#R7G&70X]M8"[P
M^I:/[@J+0YV.05&^+QS?99D?Z@II&=L1^.O9Q=.0SOY1<A9$G$3G.E99/3UU
M%6I,5  JGNL4)"14RZ((AW\;E5=,!]0*'-2^PF2O;<QL[>,@E<./U+7=/N]$
M?BMBUW3:8V]-P=Z7LSNH%S76[ND^7SBHO,P4%GH%:(?+WC2W[R/D$5R*,;2W
M@J'>,5WJ$:@0RAG$]%NV!J9>:H8@?&":@'<(*"!OB$ ]W*BF[3;ZM+F;<$N#
M='BK<![V.+7-:VOG^A7#B>Z^S,K W"-R39<O/\+'.B,9KXM-75/L-*>)4E.D
M?D=LFP&,9*6V)\L6Q^O&6X"<592%-B,3,L@U^>@U@(:+M4')PL0LLU9N3>]%
M9LO[%$5R?E 2#R>[.S=ENVW=;8+8MAD9K9I,C@]K'- &KB#&?/B5"=YX?([/
MG;=9G==[80W#OEM$)D!)X 4E'V:)Z!]F,;G*)?\ [W-G2=@/YB:T2(& 1*8
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,O"(X1'"(X1'"+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2019515d1_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2019515d1_ex99-1img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "+ )<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHK#U;7(-->*TAAGU'5[I2UGI%BJ/=S1AMCW,[.R0:?IT386?4[Z2"SCD:.W2
M2:\GMK6X -LL!U('!))/3'//H,9.3Z5R<OC"QFEDMM L[_Q3<Q.T<QT6. Z9
M;LGRRBXUZ_GLM"$L#E4N+&WU"YU6,MD:>ZI*4A/ANYUO,OB^XBO8'.X>&;&2
M9/#L*<$0ZCO6"X\3L,[96U6*+2IML<D6@VDP9WZHQ&.V\BQ\BU,<!BM!Y&^U
MMRD>R &VBEMB\$1" P136Y:-3&DL7#J <MY'CG4,^;?>'_#<#@*T%G:7?B/4
MT3Y3YD.IWLNCZ;!<CY@4ET#5+>-L?-< 9,%QH,%N]JFM^./$LSW]X+2PBN=9
MTS0FO+UH9KI;"S70-.T%[JX-O:7$ZV\9DG,$%Q( 8XY6'Y>?"KX\?M-:%\,_
M@)^T_P#%+XO6/C;PSXJ^+&C?L^_M9?!%_AKX-\(^'_@A\2?$7Q3/[.FJ:G\'
MM;T<R>/(M.^%?[20T[PSXJMOBEXP^($/B#X37^M>-89_#.K:#;Q:CZ1_P4[^
M%MO\6/!_[*.C-K=WX1U;2?VT_A9JO@WQ[IMNMWJGPW^)6I> ?BWX*^%WQ"TV
MT:XM(M1N?"/Q&\6^%]7DT6ZNH-/\2V5O=^&M69]*UB]AD=@/O"S\.^#M6N=5
ML].\1^(-0N_#FI1Z-KUKI_Q2\;SW.B:O-I.F:]%I>M6]IXL:33]2DT36]&UF
M.QOTAN6TG5],U!(39WUI-++/H7AVPOM.TT^*?$&EZMJ[W1TJRN/'NMW-]J;:
M=;":^&G:?KNK:A]N6RMF%Q>);VTJP1L+B< ;9*_/_P#X)X_%NZ^*7Q)_;HN]
M?T>U\)_$+_A=_P )]7^+'@*"[-Y+\/OBK9?LN?!?X0>._";32I#<WFF0>(/@
MM>ZIX-UVXMK8>,/ .J^%/&=A%_9/B+3W?YM^+?QAL_&G[;'@#XW2^"?B-?>&
MOV?_ -JWX7_LI?!GQ['\.]=UCX71W/Q"O?%/P"_:CUZW^(ME'<:'X9N_$'Q9
M^+G@SX,ZQ9:]#IQD\5?LV6EAH^J7MUXBET^! ?M!_87B>S ;3?&ES=MAE,/B
MC1=)U2U"\%3$= B\)WR2@@J9+B^O(RA.8&;#!/[<\1:7QKGAQKJV4_O-4\*W
M$FKI&FXAI;G0[B&TUQ&(VM]ET:#Q'* V=S!7*]B>G&>P]^OOW_K7SY\.OVC_
M  /\3/&MYX*T/2_%UC.8OB+=>%?$&MZ586OAKX@Z?\)/'%C\-?B7?^$KVRU;
M4KY8?"'CC4].T.[M_%.F>&-1U,7MOK/A^RUG0)!JIZ:.#Q6(I8FO0H5*M+!T
MU5Q-2"CRT:<FTI3;G%Z\LY6A&I)0A4J."ITZE2'/6Q>&P]3#T:]>G2JXJ;IX
M:$VU*M.*3<86A)7]Z*O.5.+G.%-3=2<*<_<-+UK2]:A>?2[V"\6&3R;A(V*W
M%I.!DVU]:RB.ZL;I1CS+6[AAN(SP\:FM2N?U7PYI6JS)>O'+9ZM @CMM<TN0
MV6L6Z*Q98!>Q#-S9>:PEDTN_6\TJY=4-W8W"JH&<-8U+P_E/%#0W&F# B\46
MD)@MX4Q_S,=B&E&D[%YDUBWD?1)"DT]XN@*UM:R\QT'8T4 @@$$$$9!'((/0
M@]P:* "BBB@ HHHH *#T./2BL37-5?3+:-+6);K5=0G6PT>R9F5;F^E1W#W#
MH&DAL+*%);_4KA%>2"PMYWABGN?(MY@!NIZG<+.NE:2D4^L3Q+/_ *0KM9:5
M:.\L:ZGJ@CDBE:%Y(9(;"QAD2ZU2[C:*)[:TM]1U+3I=(T:VTE)BLEQ>7UVT
M<FI:K>LDE_J5Q&FU9;AXTBABB3+"WL;.&UTZQ5WAL;2VA/ETW1M,BTB&6-IV
MO=0O)FOM5U"4*MQJ%[(J127,D2LWDP11PQ6EE;(6BLK&WMK.)BD*D_"?[6GQ
M"^,7A#XC?#G0?!WC/6_ASIWCF+2/#_PP\7"Q\#O\(I?C!-KFJ7&O:-^T9J_B
M[2=1U2#PE-X+MM*D^'OA3P3J?@WQ/\1==D\6^$]%\5:;XNNO!VLZ#Z64Y95S
M?&QP-&M0H5)4J];VF(=104</2E6FE&E"=6;5.%2I)4H59QHT<15C1K^PE0J^
M?FF8T\JPDL95I5JT(U:-)PH*'/S5ZL:4+RJRA3@G4E""E4G3@ZM6A3E5H^V5
M:GTW[5DWQ)\5>.?A'\*/A7K/A#P3\0)--\;_ !R^&WC3QL/$LVDZK\0/@U?>
M"K&V^%[0^&=:TEH-*\?>%_B%XGTOQY>:A:^);J#X>2>);OPQX/U?5["76O"O
MT=\&?BKH7QH^'>B^/M"MKO2FO9M6T;Q%X9U-H3K?@GQOX6U>]\->.? GB%;=
MY(%U[P9XLTK5_#FJFWDELY[K3GNM/N+K3KBTNIO/1;_#;]J7X3:=K_B73]3T
MW2=$\9^*-1T#Q#9:])X9\0>$?%WPN\5^*_ C_$'P1XT\+ZS))I4%R=+UNYT?
M7M)UR:PUSP1KUQ8:HVHZ#KFJZ==?A;^UI_P6P^#G[-.GZO\  []@KPUX=^)W
MBFQOK\>)?C3XHFU76_ATGB>XVPZSKL6H?VA;>)OCAXRO9XC)JGC2\\06^@7M
MY%#<C7_%L:36"?=\/<'YWQS2PW"_#V18K$9YE.)G#&XB5.EALNRVE7Q%>6,Q
M&;9S4J3I0H8F^"EA\'.$L3A\9@L2\%2Q6'QM>E0^)SOBG*.#:N(XCSS.<-1R
M;-,/">$H*I4KX_'U*5"C'"4,LRJG"-2=;#6QBQ&+A-8>OA,7AUBZF&KX.C4K
M?J/XY_9)U1?$/QJ'BGXV^#_ G[('Q*^-/@;]I3Q[X'_X1=M+\9?\)=X:MOA]
M=>*O"LWQ:U[QD/"7@SX2^-_''PQT+QUXO@T[P WC?5-5\7>/[73/'/A4ZM8W
MUKPWQZ_X*E?\$P-%-GH/Q$^.?@CXFW7A/Q9X:\9:5H_P_P!#\3_%5-.\8^"=
M9M_$/AC6K/6/!.CZKX<@U/0==L+.^LY)M;C$5W"H=2@D%?Q-?'K]I+X]_M0>
M(&\2_'_XK>+_ (H7R7,MUI^G^(-06/PKH,DDADV^&O!6FQ67A'PW&A.!_8NC
M6DL@"F>6:3+UXDHP,$#Z=@/3 X ]AQ7])<.?1,RRG1IU>+>*<;BL2XQ=3!</
M8>A@\)3DTFZ?]H9E3Q6+Q"B[Q=2G@<+&6KA%)IGX)G_TF\QG5J4^&.','AL.
MFU3Q>>5ZV+Q52-VE/ZC@)X;"T+JS4*F,Q$E=*4F[H_LHL?\ @NM_P36\(>+O
M&_C#PI\+_C%!XK^(]YH=[\0O&GAGX,>#=(UCQW>^%]%M_#/AJ]\5ZG=^--&U
MOQ#<Z#X<M+30]&GU=+B?3M&MK;3;4PVT$4"=%H7_  6!_P""3GQ$\(6?PO\
M$B^)?AMX%A\4^'O&-GX;\0?!KQ3H7AZP\6>&?B!IOQ5T/Q%&WPP@U^VL-1L?
MB1I5AXUDU!9HFN/$$+ZC?27$EQ<--_%O2$@?Y_,_A_\ 6]*^TK?1;\,*E)PI
M5.*</4M95X9[3K33M\7LL1E+H/ORV4>BLCY*E](WQ%A5YZD>'*].]_8RR:=*
M-K_#[6AF:K+32][]=6?Z1?@3]I#X"?M5>"_$^E?L[?M'> ?$.M:QX8UJQL=8
M\!>(]"UGQCX*O-1TZYLK'Q+)X0OIAJEG>Z'=S1:C;6NNZ5;P2W%JD5PAC9Q4
M7[/?PB\??#W7_B;XI\=W7@RRNO'\WA2>7PO\/;KQ'?>%KKQ-H6EW5CXN^+5U
M_P )-9V%QH_C7XM2S:.WB[P_H]L^CVJ^#]&U*\UOQ5XHU3Q%XBO_ /.J\&>"
M/&GB34;;6/"&GWD5]HMW'/8^);:]30YM(OX"'BFT[7?M%I=V]_"P60-IDS7E
MNP5F\H%-W[4_LS?\%<?VY/V1QI>D_'FWN/VEO@O;2107S>)];AN_B?X>M9"(
MHY-$^)<<DU[?B*1U=;'XC:=KD=^4ATVS\2>'UD$R_FW%7T6>*<JRC,JG V:4
M\]P&)4*F(R[.,OH9?FLZ="<*JIX+-J4Y9;7?-2@_9XFE@N:I%NAB,-5K5YU_
MH^'_ *67AWCN)\NR+C;%Y7D?$=&I]7P]/+,_I8NFL1BH.$8XS)*TXYE0K2A6
MERPI5\17=.<%4P.*A##TJ?\ 33\+?$_QP^*^H>"OC%I/Q/TO3O#'CCQ?<^(=
M)^ NH6O@R#2;?]F1AJ^BZ!XSO;F#PMJ'Q-O?BSXAF7P_XQN]GC32_!7AVYUB
M'P+/HT\VB:EJOB'[#UOQ+I?AU]$AU/\ M!G\1:[9>'-,BT[0]9UMY-2OXKB:
M(WHT:POQI>F0P6EQ-?:YJQLM%T^-5^WW\#RP+)\C?L:?'3]CW]H_PMXL^-7[
M*FG>"8-9\3WMM=?%FQTGPGH7@OXIVOBB<ZAJD&F_%'388+749-2FO[W7+FPU
M6\OM2\.:U?W6MZQH&NZK#=7VHS=5X/T>+X;VWC?]J?\ :<\0>%_"_C2Y\,WB
MZQ=7VN6__""? #X2VUU;ZG;_  V\.:]>K;PS&>>QTG6OBCXP'E3?$?X@6L%Q
M:6]EX2\/_#SPKX8_F+.<%..:8W!8O+<3DV(RR<,NH9#5R^GA,[J8W$3C'#Y?
M4P^&I2J5H8;W6\QK4Z^)Q-.=)1>,Q.;4(X/^H<IQ:>6X/%X7,*&:T,PA+'5\
M[IXZIBLGIX.C"4J^.A7Q%2-.C/$*Z6 HSHX?#5(S<EA</E==XOW\6TGA0F>Q
M2:;PRS%[G3$!ED\/ LS/=Z1'M9WT="^;G1T++IT*^9H\:00G3GZ^&:*XCCF@
MD2:&6-)8IHG62*6*1=T<D<B%E>.1"'1U)5D964D$&O'OA7\=_ 7Q@EU"V\*K
MXIT^\LM&T#Q5!I_C+P=XD\$ZGK'@KQ8VI)X5\:Z/IOB?3M-OKOPYK\FCZK#:
MRO!!J-C<V,EMK6FZ7<2VT4_90D>%M2AL_N^&]9N1#9$G]WH6MW4I\K3PQ.(]
M)UR23&F1$)%IVKYTR!WAU;2K*P^9Q&&Q&#K3P^*HU</7AR\]*K'EG%27-%M*
M4DTTG9QG)7C)7YH3C#Z3#XFABZ4:^&K4Z]&=U&K2ES0DXNTE=J+33:NI1B[2
MB[<LX2GV=%%%8&P4444 %<!8ZC9.FM?$35YQ;Z)8Z=?KI%Q(CRQVGA?33)=:
MEKL(A25Y8_$+6B:E'):B47>BV.@R1(96D0ZOBZ>9M/M]&M)7AOO$U_#H4$T3
M>7+;VT\4]YK5W%+_ ,L;BST"SU6YLI""&U".SAQF9:C\5>+_  5\-/"M]XG\
M:^)?#7@3P5X=M;;^T/$/B;6-.\.>'-%M3+!8V:WFJ:I/:6%FDES+;65HDLT9
MFN)H+: --+&C73A*I5ITX4ZE:=2I"G"C1C.=:K*4HI4Z4(4ZLY5)WY81A2J2
M<Y1M3F_=E%6<:=.I4G4ITH4X3G*K5E&%*G&,9-U*DISI0C3A;FG*52G%1C)N
M<%[T?--=T'P?\=O">E_$CX1?$32=+\0ZAX?GM/AU\>OAVGA/Q?/;:1/KFEZS
M>:3#?75OJND>)_ VL:[X8TR'Q?X5>XA@U5-/DMX;[1M;M;35M.?X/O?%OC+P
MEXM\(_M&?#3PGI\NB(FG^(K^.?3/$OP=^)NA/:F[/BO0+'7I;C5M&TN3[-(V
MO^#/'-@;WPCJ"/80:[XTT:+3?&6M>=I\)_ /CR>7XZ?LM?%32O 7B?Q==?VE
MJ?C;X97>B^._@_\ %B>VE\F<_$SP!9ZD/!_C2ZE:%+2\\:>&]2\(_%FUBM8]
M*L?B-I^EB^TR[_'O_@O;^W;>_#7P9IO[&7PNUJ6P\9?%;P^GB/XS:MIMQY=Y
MH/PGN[R[LM.\&Q7-NYDM;_XDWVFZC#K40,=Q'X)TZ\M)XS:^+K.<?HO"G"N.
MXSXBRGA#)9U'6Q>*E4G7S'!XG#9MPGAL#.G5S*OB*U"5&%7"T*#E[*C"=.G4
MQKPZHX/*,?7JNK\#Q+Q)@^%,BS/BG-X05+#8:,(T<!BJ&(ROB?$8R$Z6 HT*
M595ITL36K*/M:TH5)PP?MG5Q6:X*E3]C^<__  57_P""K-_^T'?ZI^S)^S%J
MC>$?V7/";2>%M=U[PM*-(/QM&E*--^P6']F+;)IWP8L(X'M-$T.S<6?CJQV:
MIJL1T!M+TH?A6$4     8 '  '(  Q@#L!CH*^H?AK^Q-^U;\8/A)<_''X5_
M!/Q!XZ^%MGXD'@Y_$/A_6?!<U]-XH;5]'\/Q:#IW@V;Q/;>.-4OI=9U_2-.M
MDTSPU=0W$MXK02/!;W4L'4:I_P $^_VQ-+^/VG_LNCX+:GJWQUO_  =IOQ ?
MP1X?\1>$-:CT?P?JEQ+9Q:]XD\5V>O-X+\.:=:WL0L;V[U?Q#:VL-]<6-E'<
M376H6$=S_HGPK3\/.!,K?"V39SD&$_LBGC*^;1K9OEO]ISQ. IX:6<9IGLY8
MB-98JF\5AZF-K8OV5/"0Q6%PM"-.C["A4_A/B2IQSQEF*XBS;*LZQ+S.IA*.
M6.EEF8?V?"AC9XB.59;DT%AW1>&J+"UX8.EA54J8J6&Q&(JNI5]M6I_'%%?:
MW[1__!.K]LO]DWPG;>/OCC\&[KP]X$N+VSTR;QEH?B?PCXTT#2=3U">&TT^Q
M\03>%-:U2[\/OJ%Y/#9Z?=ZO:6FEW]_-#IUG?SW\T-L]S]G?_@FU^VM^U1X+
M7XC_  7^"UWK7P_GN;VSTSQCXB\4^#O!.C:]=:==W%A?IX='BG7--U+7;>QO
M[2YL+K4]-TZ?2(K^WNK%M1^V6T\$7T#XSX064K/GQ1P\LDEB/JD<V><8!9<\
M6G9X18KV_LWBE:[PRB\0H?O'15+]Z_#7"G%#S-Y*N'<\>;JA]:>6+*L=]>6&
MZ8EX;V'M%AWLL0W[%R]Q574_='PX6 SDXP,DGIC_ #_@.:C9MRED.2,XQ@\]
M0#UY) QU&>#7Z#?"?]E#XH_ W]OS]ESX&_M3_"!_#EQXH^-7PG74_!_BV+0/
M%'A;QKX-UCQG9:9=R6M_I%_KGA7Q3X>OMEYINH1VM_=I#/'/8:G;VUPKP#Z"
M_P""XWPH^&/P<_;7T7P=\)?A]X-^&?A27]G_ .'NN2^'/ GAO2O"VB2ZS?>,
MOBA:WNK2Z;HUK:6;:C=VNG:?;7-X8?/F@L;2)W984QYT>.LJK\69!PM@H_VC
M'B+AK->)\#G>!QF"Q.5RP65XJAA)TX2I3JSQ$\1.OS4JU"HZ,%3J0JI5$XP[
MWP=F5'AK.N(\8W@7D7$&6\/8W*,9A<70S%8K,<-7Q49RC5C3A1A1C0Y:M*M3
M5:3J0G2;@U*7P;\4-0OM ^'7PUTCPY<3V&A:II237LVGRO;->3KIVFW:PS30
M,CE+V>\O[VYAWA;F= TP80@!/@'J>I:K-XH\.:I/<:EX8;0VGGM[Z62ZM[26
MXG2U>.)IV<017EF]V\L*E(V:V2<*KQNQ;\.53XE^ -6^'6II-'=:!LO_  ]K
M;6\LMM9.\DS6L%S.B;5DMI9YX!;,ZR7.DW,P@^:Q#"EXLU[1/AGX=O\ X<>$
M)9;O7[\!/&'B&2)HGB>>!1-9VV>5GEM6%M%'%O@TZQFDD\Z74KF66/\ 65/E
MJT,U=7EP:PL(*ES-.56G1EAYX&%)NTE.I%U)2Y735)N<FY)I?Q1/"1Q&2\0^
M#M#*5BN/*_%^-QM7.%A*<H87)\RSZCQ+A/$+'9NH.K0KX3+<1'+L/AUBX9C/
M-*5++\-1AAJG,\+]G_\ :$^+/[+GQ2T3XO?!#Q?>>%O%NARB!R&EGT/Q9H N
M(Y;KPIXTT998;;Q%X7U98E^U:==%)K6X$&K:1=Z7K=EI^J6G]NW[-O[37@S_
M (*?_L^>"_B!\.-9T+X??%WX0?$3PCXN\;?#;Q9I,OC[P_X3^(OA^RU<:-!X
MI\-6FM^#]1\4^!=7:>X\8?#3Q-:ZQHUS8>*- T#Q!%Y?B;P-JFA6_P#!$N!@
M<#@8QP, 8'7_ /7V[5]<_L/_ +7GC']B/]H7PI\;/#)OM1\.H5\.?%/P;:2#
M;XY^&FH7EM/KVC1PRR1VXUW3C;0Z[X2O9&C-EX@TVTBEE_LN_P!6M+O^=/&#
MPMPW'65O-\GH4,-QODM"I6R?'*G22S*E3IU_:9%F//RPKT,72JXBC@:M>3E@
M<56A&%:EA,7B84?] O"WQ&K\&Y@LKS2M7Q/"&;5:5+-L+*I4;P-2<Z')G6"Y
M+RHU\/5I4*^-IT(*&,P]*I*5*>)PV'E4_O$\(^ _@M^R)X5\3?$/QCXI\/>%
M)==@\.67BOQ9K&IZGH?A"R?3UN?['\ _"GPGXD\2^*)/ /@23Q1K/B75_ ?P
M9\*ZKJ=O8Z]XNU33O#\%_<WMO"?:_!_B_P %_&/P)8^)?#%])K'A;Q-92 >?
M:7^BZMI\X8Q7FE:SHVI06&O>%/%>@WR/::OH.LV6E^)/#&MVD^GZI8Z=JUC/
M!#X9XL\)6?Q>E^&G[07P"M_A9XB\5>)_#.C?\(?\:?B1<^,?%VD?#WX:>(=-
MOM9B\7_"SX9PRVVD7OC#Q';:Q%IUZ;36?AA?ZGI=S;GQ9XGUNP\.:=X1O/8?
MA'\*M/\ A-H&K:;%XB\2^,_$'BCQ)J/C3QSXX\7W-A+X@\8^,-5MM/T^]UJ\
ML]$T_1?#.B01Z9HVD:1IFA>%M!T/0=*TG2K&WM=.$WVJYN?\Y\R^K5L)+%XW
M&XVMQ!4Q"IXC#XA1BZ/U>5;"XC#5<,J2GA*>$]E"&'GB,3]8KU(5:,,NPV'H
MU<9B?[QR[ZQ1Q,<+@\'A*610H2J4*U!R:JNO&EB*&(I8AU.3%3Q7M9SKPH8?
MV%&$J5:>/KUZM/"8?L?#>H75S;7.FZG)YFLZ#='3-2EPB&\"Q1SZ?JP1%2-4
MU?3IK:^D2%3!:7SWNFJ[26$N.DKC]6/]E>)-#UE<BWU<_P#"+:J-P5 TGVB^
M\/7TI8X/V?4%O-(AB10\LOB16+[8 K=A7SY[P4444 <AQ?>.=AYB\.^&X[A
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M[B^C;D%6,.*N*,SPF%HYG'$X/@_#5,-'$*D\!DV'AC<16PZQ5?%5(4\77Q^
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MOAOYQ?6/%_[3/PF^(GP3^*?C3Q<WQ>\-W'A+]H'PSX$^*'[&'B;P7%XH\)>
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7"JH"@  5)10 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2019515d1_ex99-1img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2019515d1_ex99-1img03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I 0X# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
